Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nass Valley Gateway markets a broad portfolio of hemp-derived cannabidiol products with zero THC content. Their offerings target pain relief, dermatology, anti-aging, beauty/wellness markets and include ingestibles and topicals such as gummies, oils, skincare items and more. No clinical trial data or prescription drug development reported; all products appear to be commercial consumer health goods.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nass Valley Gateway.